Bioprocessing White Papers

  1. A Molecule’s Journey – Break Down Roadblocks To Commercial Success
    1/4/2018

    A guide for today’s biopharma executives seeking to navigate through the important considerations necessary to successfully build their own cGMP biomanufacturing facility.

  2. Scalable Strategies For Parenteral Dosage Form Selection
    12/29/2017

    Understand the strategies which can be employed at the different stages of development when choosing parenteral dosage forms.

     

  3. Single-Use Automation: Unlock The True Potential Of Single-Use Tech
    11/9/2017

    Discover how through automation, it is possible to achieve data acquisition, process monitoring and control, and batch record generation, allowing more complex unit operations to be run in cGMP environments.

  4. The Race To Phase III: A Cautionary Tale Of Scalability
    10/30/2017

    Follow the paths of two companies as they learn how a science-led, risk-based development approach yields a more successful outcome in the long run.

  5. Successful Commercial Strategy For Advancing A Molecule From The Laboratory To The Clinic
    10/24/2017

    Experts share some key considerations to help biopharmaceutical companies successfully advance a molecule from the laboratory to the clinic as quickly as possible  without sacrificing product quality, process efficiency, or patient safety.

  6. Laying The Foundation For Viral Safety
    10/20/2017

    Mitigating the risk of viral contamination in vaccines, cell, and gene therapies.

  7. Understanding And Defining Laboratory Capacity In Biopharma
    10/19/2017

    Examine the options available for measuring your laboratory capacity.

  8. Viral Safety In Monoclonal Antibody Manufacturing
    10/19/2017

    Experts share their unique perspectives on the various technologies to prevent, detect, and remove virus contamination.

  9. Advances In Upstream Technologies Reduce Viral-Contamination Risks
    10/18/2017

    Multilayered approach includes virus-resistant CHO cell lines, advanced filtration technologies, and careful raw material selection.

  10. Purification Of Antibody Fragments And Single Domain Antibodies With Amsphere A3 Protein A Resin
    10/12/2017

    The wide range of antibody fragment variants for which Amsphere A3 can be used as a capture resin is described, together with insight to the related binding mechanisms obtained via x-ray crystallography.